Advertisement

Topics

Eleven Biotherapeutics to Report Third Quarter 2017 Financial Results on November 14, 2017

16:30 EST 9 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a late-stage clinical oncology company advancing novel product candidates based on its Targeted Protein Therapeutics (TPTs) platform, today announced it will host a live conference cal...

Other Sources for this Article

Stern Investor Relations, Inc.
Michael Schaffzin, 212-362-1200
michael@sternir.com

NEXT ARTICLE

More From BioPortfolio on "Eleven Biotherapeutics to Report Third Quarter 2017 Financial Results on November 14, 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...